scispace - formally typeset
Z

Zichun Xiang

Researcher at Peking Union Medical College

Publications -  36
Citations -  4273

Zichun Xiang is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Respiratory tract infections & Innate immune system. The author has an hindex of 15, co-authored 31 publications receiving 2837 citations.

Papers
More filters
Journal ArticleDOI

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.

TL;DR: It is shown that the SARS-CoV-2 spike protein is less stable than that of SARS -CoV, and limited cross-neutralization activities between SARS and COVID-19 patients’ sera showlimited cross- neutralization activities, suggesting that recovery from one infection might not protect against the other.
Journal ArticleDOI

Activation and evasion of type I interferon responses by SARS-CoV-2.

TL;DR: This study shows that Sars-CoV-2 perturbs host innate immune response via both its structural and nonstructural proteins, and thus provides insights into the pathogenesis of SARS-Cov-2.
Journal ArticleDOI

Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007.

TL;DR: The viral detection rates differed significantly between infections of the lower and upper respiratory tracts in the sample population: PIVs, the second most commonly detected viral agents in lower acute respiratory tract infections (LRTIs), were more prevalent than in upper acute respiratory tracts, indicating that the pathogenic role of Pivs in LRTIs should be investigated.
Journal ArticleDOI

SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.

TL;DR: Wang et al. as discussed by the authors reported that SARS-CoV-2 nsp12, the viral RNA-dependent RNA polymerase (RdRp), suppresses host antiviral responses.
Journal ArticleDOI

Coxsackievirus A21, enterovirus 68, and acute respiratory tract infection, China.

TL;DR: During August 2006–April 2010, in Beijing, China, 2 rare humanEnterovirus serotypes, coxsackievirus A21 and enterovirus 68, were detected most frequently in human enterov virus–positive adults with acute respiratory tract infections.